Ads
related to: rsv treatment- Dosing And Safety Info
Info For Patients.
Click Here To Learn More Today.
- FAQs
Stay Informed.
Visit Official Patient Website.
- Find A Pharmacy Or Doctor
Learn More.
Get Protected Today.
- Protect Yourself
Learn More.
How to Prevent Virus Infection.
- Dosing And Safety Info
Search results
A Novel Broad-Spectrum Antiviral with Activity Against RSV
Digital Journal· 1 day agoIn this study, extended dosing of NV-387 given orally was compared with a high dose of ribavirin given orally for the same duration. Two doses were given on first day of dosing followed by one ...
NanoViricides unveils new data showing lead drug asset’s strong activity against RSV
Proactive Investors· 1 day agoThe company said that animals lethally infected in their lungs with RSV achieved full survival upon...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
NanoViricides Has Filed its Quarterly Report
Digital Journal· 3 hours agoSHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly ...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna Stock Slips as FDA Delays RSV Vaccine Approval
Investopedia· 5 days agoModerna (MRNA) shares lost ground in intraday trading Friday as the biotech’s effort to move beyond...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoIt will cost $3.5 million for a one-time treatment. And European regulators gave Pfizer the nod for...
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
InvestorPlace via Yahoo Finance· 6 days agoHere’s a question for you: What determines the value of a drug? Is it the number of lives it saves...
NanoViricides to showcase lead drug asset’s progress at global conference
Proactive Investors· 5 days agoNanoViricides (NYSE-A:NNVC) announced that members of its leadership team will be attending the EF...
NanoViricides CEO discusses NV-387’s broad-spectrum antiviral potential
Proactive Investors· 2 days agoNanoViricides (NYSE-A:NNVC) has released a slew of new data supporting the safety and ultra-broad...
Ad
related to: rsv treatment
